Free Trial

Phio Pharmaceuticals (PHIO) SEC Filings & 10K Form

Phio Pharmaceuticals logo
$2.74 +0.23 (+9.16%)
Closing price 04:00 PM Eastern
Extended Trading
$2.63 -0.11 (-4.01%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Phio Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/25/2025
7:46 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
3:30 PM
Carson Lisa Cabott (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/12/2025
6:49 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
3:59 PM
Ferrara Robert L (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:00 PM
Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
3:43 PM
Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
8:04 AM
Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
7:20 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
3:42 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2025
2:02 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2025
3:09 PM
CVI Investments, Inc. (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/28/2025
11:15 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form EFFECT
01/28/2025
3:16 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
01/23/2025
2:45 PM
Orca Capital AG (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
Form SCHEDULE 13G
01/21/2025
3:39 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/17/2025
3:44 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
Form SCHEDULE 13G
01/17/2025
7:00 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 424B5
01/15/2025
7:00 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 424B5
01/14/2025
4:18 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
12:34 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 424B5
01/13/2025
9:55 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:06 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
12/27/2024
4:05 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
Form SCHEDULE 13G
12/26/2024
1:19 PM
CVI Investments, Inc. (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
Form SCHEDULE 13G
12/23/2024
3:05 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 424B5
12/20/2024
7:00 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 424B5
12/19/2024
7:38 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
10:20 AM
INTRACOASTAL CAPITAL, LLC (Filed by)
Phio Pharmaceuticals Corp. (Subject)
Phio Pharmaceuticals (Subject)
Form SC 13G/A
11/07/2024
9:21 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
1:59 PM
Bitterman Robert J (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
1:59 PM
Freeman Jonathan E (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
2:00 PM
Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:10 PM
BRADFORD PATRICIA A (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:11 PM
Ferrara Robert L (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
3:11 PM
Lockshin Curtis (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
3:14 PM
Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:45 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
8:05 AM
Infarinato Robert M. (Reporting)
Phio Pharmaceuticals Corp. (Issuer)
Phio Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/05/2024
7:00 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 424B3
08/01/2024
11:15 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form EFFECT
08/01/2024
7:00 AM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The $7 company helping Nvidia build the world’s first trillion-dollar robot … (Ad)

Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profitable trends in tech … well ahead of Wall Street. Like when he called Nvidia at a mere 80 cents a share. Or Bitcoin when it was trading for just $300. Throughout his illustrious career … Michael has given his followers almost 150 different chances to register triple-digit gains.

Now he's identified his next potential winner. Click here to find out more.
07/26/2024
3:30 PM
Phio Pharmaceuticals Corp. (Filer)
Phio Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PHIO) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners